Switch to:

Beam Therapeutics Additional Paid-In Capital

: $494.75 Mil(As of Mar. 2020)
View and export this data going back to 2020. Start your Free Trial

Beam Therapeutics's quarterly additional paid-in capital declined from Sep. 2019 ($301.51 Mil) to Dec. 2019 ($1.85 Mil) but then increased from Dec. 2019 ($1.85 Mil) to Mar. 2020 ($494.75 Mil).

Beam Therapeutics's annual additional paid-in capital increased from Dec. 2017 ($0.02 Mil) to Dec. 2018 ($7.26 Mil) but then declined from Dec. 2018 ($7.26 Mil) to Dec. 2019 ($1.85 Mil).


Beam Therapeutics Additional Paid-In Capital Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Beam Therapeutics Annual Data
Dec17 Dec18 Dec19
Additional Paid-In Capital 0.02 7.26 1.85

Beam Therapeutics Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
Additional Paid-In Capital Premium Member Only Premium Member Only 0.00 3.94 301.51 1.85 494.75

Beam Therapeutics Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Beam Therapeutics Additional Paid-In Capital Related Terms


Beam Therapeutics Additional Paid-In Capital Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)